Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 17/20 | 0.65 |
| ▸ | PTGS1 | P23219 | 5/20 | 0.65 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.55 |
| ▸ | KDM5A | P29375 | 1/20 | 0.54 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.54 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8953896 | 1.00 | PTGS2 (0.65) | PTGS2PTGS1AOC3KDM5AKDM4C | |
| Pyrazole SCHEMBL27457614 | 0.88 | PTGS2 (0.53) | PTGS2PTGS1AOC3KDM5AKDM4C | |
| SCHEMBL17369543 | 0.87 | PTGS2 (0.64) | PTGS2PTGS1KDM5AKDM4CKDM5B | |
| SCHEMBL7565047 | 0.86 | PTGS2 (0.61) | PTGS2PTGS1 | |
| SCHEMBL9260230 | 0.86 | PTGS2 (0.65) | PTGS2PTGS1KDM5AKDM4CKDM5B | |
| SCHEMBL8954490 | 0.86 | PTGS2 (0.57) | PTGS2PTGS1KDM5AKDM4CKDM5B | |
| SCHEMBL15756943 | 0.85 | FLT3 (0.58) | PTGS2PTGS1AOC3KDM5AKDM4C | |
| SCHEMBL7827710 | 0.82 | PTGS2 (0.54) | PTGS2PTGS1 | |
| SCHEMBL15638299 | 0.82 | PTGS2 (0.51) | PTGS2PTGS1AOC3KDM5AKDM4C | |
| SCHEMBL17086632 | 0.80 | MEN1 (0.50) | PTGS2PTGS1KDM5AKDM4CKDM5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1682143-A2 | COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA | Pharmacia Corporation (US) | 2006-07-26 | — | — | EP | disclosed |
| WO-2005044194-A2 | TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR | PHARMACIA CORPORATION (US) | 2005-05-19 | — | — | WO | disclosed |
| WO-2005041879-A2 | COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA | PHARMACIA CORPORATION (US) | 2005-05-12 | — | — | WO | disclosed |